G. Magariños

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis

A. Paller, K. Papp, J. Cather, 2022, JAMA dermatology.

Intermittent use of biologic agents for the treatment of psoriasis in adults

C. Chu, G. Magariños, Z. Ruszczak, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Eruptive lesions in a patient with bone marrow transplantation

M. Marini, A. Saponaro, G. Magariños, 2001, International journal of dermatology.

Yellowish Papules on Flexural Areas of a Child

M. Peruffo, G. Magariños, M. Larralde, 2002, Pediatric dermatology.

Cutaneous sclerosing perineurioma of the digits: an uncommon soft‐tissue neoplasm. Report of two cases with immunohistochemical analysis

C. Ortiz-Hidalgo, G. Magariños, P. Olsoff-Pagovich, 2003, Journal of cutaneous pathology.

Effects of castration, androgen replacement and flutamide treatment on the contractile function of the rat prostate.

G. Magariños, J. Hib, 1989, Acta physiologica et pharmacologica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y de la Asociacion Latinoamericana de Farmacologia.

Case report: diffuse plane xanthoma with low C4 and systemic inflammatory symptoms.

M. Marini, J. Casas, G. Magariños, 2009, Dermatology online journal.

Efficacy and safety of ixekizumab in a phase III, randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis (IXORA‐PEDS)†

A. Paller, E. Edson-Heredia, K. Papp, 2020, The British journal of dermatology.

Eruptive lesions in a patient with bone marrow transplantation

M. Marini, A. Saponaro, G. Magariños, 2001, International journal of dermatology.